首页> 外文期刊>Chinese journal of cancer >Ultrasound-guided fine needle aspiration of retropharyngeal lymph nodes after radiotherapy for nasopharyngeal carcinoma: a novel technique for accurate diagnosis
【24h】

Ultrasound-guided fine needle aspiration of retropharyngeal lymph nodes after radiotherapy for nasopharyngeal carcinoma: a novel technique for accurate diagnosis

机译:鼻咽癌放疗后超声引导下咽后淋巴结细针穿刺:一种准确诊断的新技术

获取原文
           

摘要

Background Enlarged retropharyngeal lymph nodes (RLNs) are very common in patients with nasopharyngeal carcinoma (NPC) undergoing radiotherapy. The most suitable treatment option for enlarged RLNs depends on the pathological results. However, RLN sampling is difficult and imminent in the clinic setting. We recently developed a novel minimally invasive technique termed endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for sampling RLN tissues sufficient for pathological or cytological diagnosis. Methods We enrolled 30 post-radiotherapy patients with NPC with suspected RLN metastasis detected via magnetic resonance imaging (MRI). The EUS probe was introduced into the nasopharynx via the nostrils, and EUS was then used to scan the retropharyngeal space and locate the RLN in the anterior carotid sheath. EUS-FNA was subsequently performed. The safety and efficacy of using EUS-FNA to sample the RLN tissues were assessed. Results Strips of tissue were successfully sampled from all patients using EUS-FNA. Of the 30 patients, 23 were confirmed to have cancer cells in the biopsied tissues via pathology or cytology examinations with 1 EUS-FNA biopsy session. The seven cases without confirmed cancer cells were subsequently reanalyzed by using another EUS-FNA biopsy session, and two more cases were confirmed possessing cancer cells. The other five patients without confirmed cancer cells were closely followed with MRI every month for 3?months. After follow-up for 3?months, three patients were still considered cancer-free due to the presence of RLNs with stable or shrinking diameters. The rest two patients who showed progressive disease underwent a third EUS-FNA biopsy procedure and were further confirmed to be cancer cell-positive. In the whole cohort reported here, the EUS-FNA procedure was not associated with any severe complications. Conclusion EUS-FNA is a safe and effective diagnostic approach for sampling tissues from the RLNs in patients with suspected recurrent NPC.
机译:背景鼻咽癌(NPC)接受放射治疗的患者后咽淋巴结肿大(RLN)非常普遍。对于扩大的RLN,最合适的治疗选择取决于病理结果。但是,RLN采样在临床环境中非常困难且迫在眉睫。我们最近开发了一种新型的微创技术,称为内窥镜超声引导下细针穿刺术(EUS-FNA),用于对足以进行病理或细胞学诊断的RLN组织进行采样。方法我们招募了30例经核磁共振成像(MRI)检测出可疑RLN转移的NPC放射治疗后患者。 EUS探针通过鼻孔插入鼻咽,然后用EUS扫描咽后间隙并将RLN定位在颈前动脉鞘中。随后进行了EUS-FNA。评估了使用EUS-FNA采样RLN组织的安全性和有效性。结果使用EUS-FNA成功地从所有患者中取样了组织条带。在30例患者中,通过1次EUS-FNA活组织检查的病理学或细胞学检查证实了23例活检组织中有癌细胞。随后通过另一次EUS-FNA活检再次分析了7例未确诊癌细胞的病例,另外2例确诊为癌细胞的病例。其余5例未确诊癌细胞的患者每月进行MRI随访3个月。随访3个月后,由于存在直径稳定或缩小的RLN,三名患者仍被认为无癌。其余两名显示出进行性疾病的患者接受了第三次EUS-FNA活检,并被进一步确认为癌细胞阳性。在本文报道的整个队列中,EUS-FNA手术与任何严重并发症无关。结论EUS-FNA是一种可疑的复发性鼻咽癌患者从RLNs中取样组织的安全有效的诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号